Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FARSØ FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   4.2% 8.0% 6.6% 6.8% 9.0% 9.0% 20.8% 19.1%   Credit score (0-100)   50 32 37 35 26 27 4 7   Credit rating   BBB BB BBB BBB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,028 2,282 2,510 2,537 2,861 5,092 0.0 0.0   EBITDA   485 -568 -18.3 -30.9 33.9 2,740 0.0 0.0   EBIT   377 -621 -62.3 -73.4 4.9 2,718 0.0 0.0   Pre-tax profit (PTP)   369.8 -628.9 -63.0 -74.6 4.0 2,691.2 0.0 0.0   Net earnings   288.9 -488.2 -50.9 -74.6 4.0 2,110.2 0.0 0.0   Pre-tax profit without non-rec. items   370 -629 -63.0 -74.6 4.0 2,691 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   199 165 121 78.5 49.5 0.0 0.0 0.0   Shareholders equity total   432 -256 -427 -502 -498 612 32.2 32.2   Interest-bearing liabilities   0.0 1,074 182 199 198 666 0.0 0.0   Balance sheet total (assets)   868 1,252 1,155 1,001 753 3,110 32.2 32.2   Net Debt   -198 986 -244 -97.4 74.0 -2,329 -32.2 -32.2     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,028 2,282 2,510 2,537 2,861 5,092 0.0 0.0   Gross profit growth   20.0% -24.6% 10.0% 1.1% 12.8% 78.0% -100.0% 0.0%   Employees   6 7 6 6 6 4 0 0   Employee growth %   0.0% 16.7% -14.3% 0.0% 0.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   868 1,252 1,155 1,001 753 3,110 32 32   Balance sheet change%   11.2% 44.2% -7.7% -13.3% -24.8% 313.0% -99.0% 0.0%   Added value   377.0 -621.1 -62.3 -73.4 4.9 2,717.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -215 -86 -88 -85 -58 -71 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 -3.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.4% -27.2% -2.5% -2.9% 0.2% 53.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   45.7% -52.2% -3.5% -4.5% 0.4% 124.6% 0.0% 0.0%   ROI %   84.7% -81.6% -5.1% -7.0% 0.6% 269.0% 0.0% 0.0%   ROE %   100.6% -58.0% -4.2% -6.9% 0.5% 309.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   49.7% -17.0% -27.0% -33.4% -39.8% 19.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -40.8% -173.4% 1,332.8% 315.2% 218.5% -85.0% 0.0% 0.0%   Gearing %   0.0% -418.8% -42.5% -39.6% -39.8% 108.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.8% 1.6% 1.3% 2.8% 0.4% 6.2% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.3 2.2 1.3 1.0 0.9 1.2 0.0 0.0   Current Ratio   1.6 2.5 1.5 1.2 1.0 1.2 0.0 0.0   Cash and cash equivalent   197.8 88.5 425.7 296.0 124.0 2,995.6 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   248.6 652.6 356.5 123.7 -3.4 612.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   63 -89 -10 -12 1 679 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   81 -81 -3 -5 6 685 0 0   EBIT / employee   63 -89 -10 -12 1 679 0 0   Net earnings / employee   48 -70 -8 -12 1 528 0 0